European Archives - Page 1039 of 1042 - European Medical Journal

EMJ Neurology 2013

Welcome to the first edition of European Medical Journal – Neurology. This issue will provide you with the highlights of the XXI World Congress of…

The Evolving World of Chronic Kidney Disease Mineral Bone Disorder

Chronic kidney disease – mineral and bone disorder (CKD-MBD) is associated with a significant morbidity and mortality. In vitro and animal models suggest…

EMJ Nephrology 2013

I would like to offer a very warm welcome to this first issue of European Medical Journal – Nephrology.

Clinical Proteomics: The Potentiality of Urine Analysis for Understanding Diabetic Nephropathy

The incidence of diabetic nephropathy (DN) is constantly rising in parallel with the prevalence of type 2 diabetes and has been predicted to double…

Treatment of Antibody-Mediated Rejection in Kidney Transplantation

Antibody-mediated rejection (AMR) is a relatively rare but severe complication in kidney transplantation associated with increased risk of graft loss.

Vascular Calcification in Chronic Kidney Disease: An Update

Vascular calcification involves passive degeneration and an active process of arterial mineralisation, resembling osteogenesis. In chronic kidney disease…

‘A Better Way to Measure Choices’ Discrete Choice Experiment and Conjoint Analysis Studies in Nephrology: A Literature Review

Discrete choice experiments (DCE) and conjoint analysis (CA) are increasingly used to address health policy issues. This is because the DCE and CA…

Is There an Interest in Implementing a Multidisciplinary Clinic or Renal Care Network to Improve the Prognosis of Patients with Chronic Kidney Disease?

Chronic kidney disease (CKD) is highly prevalent in several countries and is associated with the incidence of end-stage renal disease (ESRD) and also…

Hymenoptera Stings and the Acute Kidney Injury

Hymenoptera stings are a health concern. Apidae (bees), Vespidae (hornets, yellow jackets and wasps) and Formicidae (ants) are medically-important…

A New Combination of Factor XA Inhibition and Standard Antiplatelet Therapy to Prevent More Recurrent Cardiovascular Events in Acute Coronary Syndrome (ACS)

Coronary artery disease remains the leading cause of death worldwide. There has been tremendous progress in the management of Acute Coronary Syndrome…